Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. - Wikidata - wikimedia - TriplyDB

Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease.

Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q47987827

about

Updates on the COPD gene list Muscle function in COPD: a complex interplay Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure.Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients The ACE gene and human performance: 12 years on.A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD The prevalence of quadriceps weakness in COPD and the relationship with disease severity.Association of Angiotensin Converting Enzyme I/D and α-actinin-3 R577X Genotypes with Growth Factors and Physical Fitness in Korean Children.Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease.A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease.Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity.Pulmonary rehabilitation in chronic obstructive pulmonary disease.Allergic rhinitis, asthma, airway biology, and chronic obstructive pulmonary disease in AJRCCM in 2004.Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease.Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease.Skeletal muscle dysfunction in COPD: clinical and laboratory observations.ACE and response to pulmonary rehabilitation in COPD: two observational studies.Molecular genetic studies of gene identification for sarcopenia.Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.Should all patients with COPD be exercise trained?The D/I polymorphism in the angiotensin-converting enzyme gene and chronic obstructive pulmonary disease risk: a meta-analysis.Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease.Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine?Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease.miR-422a suppresses SMAD4 protein expression and promotes resistance to muscle loss.The association of ACE, ACTN3 and PPARA gene variants with strength phenotypes in middle school-age children.ACE I/D, ACTN3 R577X, PPARD T294C and PPARGC1A Gly482Ser polymorphisms and physical fitness in Taiwanese late adolescent girls.Human angiotensin-converting enzyme I/D and alpha-actinin 3 R577X genotypes and muscle functional and contractile properties.gene polymorphism is associated with COPD and COPD with pulmonary hypertension: a meta-analysis The Human Obesity Gene Map: The 2004 Update

P2860

Q26824935-9333097F-A25C-4E64-AFD1-00505F7E15AA Q26865732-2BFAFBE3-1037-4AA6-BDF9-0219B5C83E36 Q33360095-72A853B4-7AC1-4495-BA08-5D8DAA1D82E5 Q33813557-E7C80D71-66F7-45A0-AC3C-FAB14FC6259F Q33901722-CD9D85F6-F245-4D94-B9D7-349C8DC65955 Q34061404-B6BB217D-8D9E-4282-8FB4-EB1A2C8522F2 Q34187481-ED6F851C-0D6D-41EA-8DB7-7448835DF5A2 Q34299825-ABF9CFC5-B96B-4D73-B5D5-2B173348268F Q34436903-599BB44A-977E-4B28-8306-8BCD95810195 Q34575095-580F1EA1-6D95-4732-9756-52DBC6108354 Q35127466-514FFDFB-5DDD-4903-89F1-30745EB8A999 Q35537946-B008A38A-8CC4-4258-93CE-53D1709DB0D8 Q35699591-5C273941-B11C-4110-ACDC-37855B7DD9CD Q36036917-13D11BB1-2F0E-458C-9910-177F13C30163 Q36075213-CAC5F887-720F-4025-82AE-3F7C1AC9F095 Q36080147-82BAEA13-FA0B-4476-A19C-E61A8298ED7D Q36203206-01D25FBC-069B-4352-A136-3CC93D4D6093 Q36464180-66FB965E-2DC9-45E1-9613-936251E584B2 Q36752117-0ADC6C54-946F-411F-BBE8-3B0956DB8C4F Q37147842-AD7F5226-C459-4BB2-8B71-AC1FE9B28517 Q37490167-AE7781A3-285D-4DCB-97D4-F77E343B0A08 Q37579935-032BB9FE-33F9-47CA-A679-38DA0B29C691 Q37704113-4A3593E6-D16E-4494-9413-9CD014ADB3C4 Q37894597-E5B38256-CA63-41A7-B221-CE4E62515FC0 Q38023517-8BC002DC-147E-4261-A814-FEF2FB6D9313 Q38081828-7D078CF7-1F4C-47FD-B366-F40D010D20E9 Q39572127-2F975D12-08AE-4757-BE6C-448A7D0FA970 Q41529441-DDD00C92-5DA1-4EE9-93D9-8C659A3C272D Q46210278-41EC2BBD-4CEC-4217-97A9-79389611AE09 Q46650148-2B5B3724-9018-4208-8B38-B8DD49565FED Q47688387-018888D3-ED91-4323-B00A-68B52C568F34 Q50911057-5D8D6C9B-EF90-4DD5-A87A-D11DE9CC3394 Q51367973-1EC82544-4854-4A9A-A923-5D1A201B2948 Q54521805-97A89C47-6625-4030-A067-C627BE8C7DCE Q57169668-FFC9599D-E89A-4C7B-992C-D0D15E687965 Q57316399-FF9C3E59-CA33-4B14-8EC7-BBF9678893B0

P2860

Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q47987827

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Angiotensin converting enzyme ...... obstructive pulmonary disease.

@en

Angiotensin converting enzyme ...... obstructive pulmonary disease.

@nl

type

label

Angiotensin converting enzyme ...... obstructive pulmonary disease.

@en

Angiotensin converting enzyme ...... obstructive pulmonary disease.

@nl

prefLabel

Angiotensin converting enzyme ...... obstructive pulmonary disease.

@en

Angiotensin converting enzyme ...... obstructive pulmonary disease.

@nl

P1433

Q47987827-A8D62615-22A4-4DC2-8EBC-2CDEE8BF823E

P1476

Q47987827-4E2949FC-31E8-446C-A759-AF40AC9E3F11

P2093

Q47987827-1A22E95C-B295-4165-BD64-9B450F18D901

Q47987827-71AD9122-9655-44BA-8844-1A4F42F9DAA1

Q47987827-84D00A6C-721D-48C8-B60A-F00FA761DF2A

Q47987827-AF5136B5-F8FA-4B67-80E0-3B437A42FA1A

Q47987827-C566CA68-F214-4297-B64A-7A8C10FBF466

Q47987827-C9C0C3F2-5D06-4A6C-93A1-A8B8E66FDDB6

P2860

Q47987827-0BA94F6E-1A6A-4CCA-B86D-CF20ED413C99

Q47987827-16DB41AF-9839-40E5-AE18-46283E6C5B94

Q47987827-1758E5B2-E594-4EAD-A3E7-51E2F10C832A

Q47987827-2B203609-4A25-4B11-92C7-177C9F4B7621

Q47987827-30CB14F1-985E-45F8-8F10-B360BD9216F7

Q47987827-36735DA0-CB3D-42AB-9E88-1168D7656EC7

Q47987827-37AE45E6-3DA4-4DEE-B333-4149F349BF3A

Q47987827-3FEE5426-C739-459E-B112-A1B2C526C5DC

Q47987827-4020F073-58FD-4F67-9E61-3114A4CA8197

Q47987827-70DA3337-B0E1-47C6-B4D3-284D06DD6F36

P304

Q47987827-203DBD70-9E18-4560-8DD0-04CAE4686D4E

P31

Q47987827-A6D57192-3588-43A9-8659-96D6AC6FB0B5

P356

Q47987827-6E63822F-EDA6-432C-9FC8-8592F911C115

P407

Q47987827-60D1BB12-347A-4C65-8BA8-5C12CFAD1FF4

P433

Q47987827-29C41A7B-51FF-4228-8184-E03F134AA614

P478

Q47987827-5B72F0EE-6AE7-4B7E-9CA6-BBFE5F862391

P50

Q47987827-88E3A6C5-E505-4DEB-B014-EC6DCE5B1C97

Q47987827-F72EA29E-DFC6-4AA9-AB4C-3640AB8DB241

P577

Q47987827-13FB005D-1249-4156-9A27-94C1B33A89F2

P5875

Q47987827-E21885D1-60D6-4CBE-898E-8CF4EA3A84D4

P698

Q47987827-D6A868B1-5247-4C81-9C2F-ED1D7B2F5802

P921

Q47987827-5C3F9FB9-9460-42AA-B285-CF635926217D

P356

RCCM.200304-578OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Angiotensin converting enzyme ...... obstructive pulmonary disease.

@en

P2093

Annabel H Nickol

http://www.w3.org/2001/XMLSchema#string

Emma Hawe

http://www.w3.org/2001/XMLSchema#string

John Moxham

http://www.w3.org/2001/XMLSchema#string

John Payne

http://www.w3.org/2001/XMLSchema#string

Michael I Polkey

http://www.w3.org/2001/XMLSchema#string

William D-C Man

http://www.w3.org/2001/XMLSchema#string

P2860

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation.

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training.

Changes in force, cross-sectional area and neural activation during strength training and detraining of the human quadriceps.

Skeletal muscle RAS and exercise performance.

Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition.

Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease.

Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release.

Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example.

P304

395-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200304-578OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas S. Hopkinson

Hugh E Montgomery

P577

2004-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8587035

http://www.w3.org/2001/XMLSchema#string

P698

15117739

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease